PhoenixBio Co (TSE:6190) FCF Margin %: 29.91% (As of Mar. 2026)

What is PhoenixBio Co FCF Margin %?

PhoenixBio Co TSE:6190 -7.16% 62 FCF Margin % is 29.91% as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 62/100 and a GF Value™ of 円361.16 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 958 Biotechnology companies, PhoenixBio Co ranks better than 77.35% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PhoenixBio Co's Free Cash Flow for the six months ended in Mar. 2026 was 円242 Mil. PhoenixBio Co's Revenue for the six months ended in Mar. 2026 was 円809 Mil. Therefore, PhoenixBio Co's FCF Margin % for the quarter that ended in Mar. 2026 was 29.91%.

As of today, PhoenixBio Co's current FCF Yield % is 4.11%.

The historical rank and industry rank for PhoenixBio Co's FCF Margin % or its related term are showing as below:

TSE:6190' s FCF Margin % Range Over the Past 10 Years
Min: -28.04 Med: -5.07 Max: 12.48
Current: 3.46

During the past 12 years, the highest FCF Margin % of PhoenixBio Co was 12.48%. The lowest was -28.04%. And the median was -5.07%.

TSE:6190's FCF Margin % is ranked better than
77.35% of 958 companies
in the Biotechnology industry
Industry Median: -85.21 vs TSE:6190: 3.46

PhoenixBio Co FCF Margin % Related Terms

PhoenixBio Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co FCF Margin % Chart

PhoenixBio Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

FCF Margin %

Get a 7-Day Free Trial

0.73

12.48

-6.88

-6.83

3.46

PhoenixBio Co Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-7.70	-13.13	-0.24	-24.83	29.91

TSE:6190 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, PhoenixBio Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PhoenixBio Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's FCF Margin % falls into.

Save Embed

62GF Score

PhoenixBio Co Ltd TSE:6190

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PhoenixBio Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PhoenixBio Co's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2026 )	/	Revenue (A: Mar. 2026 )
	=	54.203	/	1565.532
	=	3.46 %

PhoenixBio Co's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	242.037	/	809.18
	=	29.91 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 29.91% mean?

PhoenixBio Co (TSE:6190) has a FCF Margin % of 29.91% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PhoenixBio Co and its competitors. According to the industry distribution chart, PhoenixBio Co ranks #217 out of 958 companies in the Biotechnology industry, placing it in the top 22.7%.

Is PhoenixBio Co's FCF Margin % too high?

PhoenixBio Co's current FCF Margin % is 29.91%. Based on the distribution chart, PhoenixBio Co ranks #217 out of 958 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PhoenixBio Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does PhoenixBio Co's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, PhoenixBio Co ranks #217 out of 958 companies for FCF Margin %. This places PhoenixBio Co in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current FCF Margin % is 29.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PhoenixBio Co stock overvalued right now?

Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Modestly Undervalued. The stock's GF Value™ is 円361.16, compared to a current price of 円324.00 — trading 10.3% below its estimated fair value. The current FCF Margin % is 29.91%. PhoenixBio Co's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current FCF Margin % is 29.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円324.00 is trading 10.3% below its estimated GF Value™ of 円361.16. GuruFocus considers PhoenixBio Co to be Modestly Undervalued.

Key valuation signals for TSE:6190:

FCF Margin %: 29.91%
GF Value™: 円361.16 vs. price of 円324.00 (10.3% below fair value)
GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhoenixBio Co Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:4598 TSE:4881 TSE:130A TSE:4884 TSE:4591 TSE:2342 TSE:4576 TSE:2183 TSE:177A TSE:206A VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046

Website http://www.phoenixbio.co.jp

PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.

62GF Score

Get the complete analysis for TSE:6190

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円324.00

Price

円361.16

GF Value

View TSE:6190 Analysis

See FCF Margin % data for all stocks →